Gsk (GSK) EPS (Diluted) (2009 - 2026)
Gsk's EPS (Diluted) came in at $1.42 for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) EPS (Diluted) (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 8, 2026, Gsk reported EPS (Diluted) of $1.54; for the year ended Dec 31, 2025, it came in at $3.66, up 130.4% from the prior year.
- EPS (Diluted) carries a five-year compound annual growth rate of 0.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, EPS (Diluted) was $1.59 in the year ended Dec 31, 2024 (-46.7%), $2.98 in the year ended Dec 31, 2023 (-67.1%), $9.06 in the year ended Dec 31, 2022 (+204.4%) and $2.98 in the year ended Dec 31, 2021 (-18.7%).
- The figure for the quarter ended Sep 8, 2026 represents the highest quarterly EPS (Diluted) since the quarter ended Sep 30, 2022.
- Year-over-year, EPS (Diluted) increased in four of the last five quarters, with growth averaging 9.8%.
- The fastest year-over-year change in EPS (Diluted) over five years came in the quarter ended Sep 30, 2022 (growth of 687.8%), and the weakest in the quarter ended Sep 30, 2023 (a decline of 85.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -0.04 |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 0.28 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.28 |
| Mar 31, 2026 | 1.14 |
| Dec 31, 2025 | -1.30 |
| Sep 30, 2025 | 1.31 |
| Jun 30, 2025 | 0.93 |
| Mar 31, 2025 | 0.99 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | 0.72 |
| Mar 31, 2024 | 0.65 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 0.91 |
| Jun 30, 2023 | 1.00 |
| Mar 31, 2023 | 0.89 |
| Dec 31, 2022 | 0.86 |
| Sep 30, 2022 | 6.29 |
| Jun 30, 2022 | 0.52 |
| Mar 31, 2022 | 1.19 |
| Dec 31, 2021 | 0.50 |
| Sep 30, 2021 | 0.80 |
API Access
Gsk EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();